Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial.

Saved in:
Bibliographic Details
Title: Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial.
Authors: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 Jan; Vol. 33 (1), pp. e70269. Date of Electronic Publication: 2025 Oct 26.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1442-2042
DOI:10.1111/iju.70269